378 related articles for article (PubMed ID: 21518598)
61. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification.
Bartholomew BA; Harjai KJ; Dukkipati S; Boura JA; Yerkey MW; Glazier S; Grines CL; O'Neill WW
Am J Cardiol; 2004 Jun; 93(12):1515-9. PubMed ID: 15194023
[TBL] [Abstract][Full Text] [Related]
62. Impact of high loading dose of atorvastatin in diabetic patients with renal dysfunction undergoing elective percutaneous coronary intervention: a randomized controlled trial.
Shehata M; Hamza M
Cardiovasc Ther; 2015 Apr; 33(2):35-41. PubMed ID: 25677920
[TBL] [Abstract][Full Text] [Related]
63. Abbreviated dosing of N-acetylcysteine prevents contrast-induced nephropathy after elective and urgent coronary angiography and intervention.
Ochoa A; Pellizzon G; Addala S; Grines C; Isayenko Y; Boura J; Rempinski D; O'Neill W; Kahn J
J Interv Cardiol; 2004 Jun; 17(3):159-65. PubMed ID: 15209578
[TBL] [Abstract][Full Text] [Related]
64. Hyperuricemia as a risk factor for contrast-induced nephropathy in patients with chronic kidney disease.
Toprak O; Cirit M; Esi E; Postaci N; Yesil M; Bayata S
Catheter Cardiovasc Interv; 2006 Feb; 67(2):227-35. PubMed ID: 16400673
[TBL] [Abstract][Full Text] [Related]
65. Proteinuria as a predictor of renal dysfunction in trauma patients receiving intravenous contrast.
Clark JJ; Wong LL; Lurie F; Kamitaki BK
Am Surg; 2011 Sep; 77(9):1194-200. PubMed ID: 21944630
[TBL] [Abstract][Full Text] [Related]
66. Risk factors and clinical outcomes for contrast-induced nephropathy after percutaneous coronary intervention in patients with normal serum creatinine.
Chong E; Poh KK; Liang S; Tan HC
Ann Acad Med Singap; 2010 May; 39(5):374-80. PubMed ID: 20535427
[TBL] [Abstract][Full Text] [Related]
67. Impact of Chronic Statin Therapy on Postprocedural Contrast-Induced Nephropathy in Patients Undergoing Non-Emergent Percutaneous Coronary Intervention.
Chanin JM; Yang DC; Haider MA; Swaminathan RV; Kim LK; Charitakis K; Tanoue M; Minutello RM; Gade CL; Singh HS; Bergman G; Wong SC; Feldman DN
J Invasive Cardiol; 2015 Nov; 27(11):490-6. PubMed ID: 25999136
[TBL] [Abstract][Full Text] [Related]
68. Impact of acute renal failure following percutaneous coronary intervention on long-term mortality.
Roghi A; Savonitto S; Cavallini C; Arraiz G; Angoli L; Castriota F; Bernardi G; Sansa M; De Servi S; Pitscheider W; Danzi GB; Reimers B; Klugmann S; Zaninotto M; Ardissino D;
J Cardiovasc Med (Hagerstown); 2008 Apr; 9(4):375-81. PubMed ID: 18334892
[TBL] [Abstract][Full Text] [Related]
69. Does avoidance of cardiopulmonary bypass decrease the incidence of stroke in diabetics undergoing coronary surgery?
Abraham R; Karamanoukian HL; Jajkowski MR; von Fricken K; D'Ancona G; Bergsland J; Salerno TA
Heart Surg Forum; 2001; 4(2):135-40. PubMed ID: 11544620
[TBL] [Abstract][Full Text] [Related]
70. N-acetylcysteine versus N-acetylcysteine + theophylline for the prevention of contrast nephropathy.
Baskurt M; Okcun B; Abaci O; Dogan GM; Kilickesmez K; Ozkan AA; Ersanli M; Gurmen T
Eur J Clin Invest; 2009 Sep; 39(9):793-9. PubMed ID: 19500141
[TBL] [Abstract][Full Text] [Related]
71. [The relationship between hyperuricemia and contrast-induced nephropathy in patients with chronic kidney disease undergoing percutaneous coronary intervention].
Liu YH; Tan N; Liu Y; Ye P; He YT; Ran P; Jiang L
Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Sep; 41(9):740-3. PubMed ID: 24331800
[TBL] [Abstract][Full Text] [Related]
72. The efficacy of n-acetylcysteine in preventing contrast-induced nephropathy in type 2 diabetic patients without nephropathy.
Sar F; Saler T; Ecebay A; Saglam ZA; Ozturk S; Kazancioglu R
J Nephrol; 2010; 23(4):478-82. PubMed ID: 20383874
[TBL] [Abstract][Full Text] [Related]
73. Impact of benazepril on contrast-induced acute kidney injury for patients with mild to moderate renal insufficiency undergoing percutaneous coronary intervention.
Li XM; Cong HL; Li TT; He LJ; Zhou YJ
Chin Med J (Engl); 2011 Jul; 124(14):2101-6. PubMed ID: 21933609
[TBL] [Abstract][Full Text] [Related]
74. Diastolic dysfunction predicts the risk of contrast-induced nephropathy and outcome post-emergency percutaneous coronary intervention in AMI patients with preserved ejection fraction.
Han B; Li Y; Dong Z; Wan Q; Shen H; Li J; Wei M; Shen C
Heart Vessels; 2018 Oct; 33(10):1149-1158. PubMed ID: 29704102
[TBL] [Abstract][Full Text] [Related]
75. Relation of homocysteinemia to contrast-induced nephropathy in patients undergoing percutaneous coronary intervention.
Kim SJ; Choi D; Ko YG; Kim JS; Han SH; Kim BK; Kang SW; Hong MK; Jang Y; Choi KH; Yoo TH
Am J Cardiol; 2011 Oct; 108(8):1086-91. PubMed ID: 21791335
[TBL] [Abstract][Full Text] [Related]
76. Contrast Volume-to-Creatinine Clearance Ratio Predicts the Risk of Contrast-Induced Nephropathy After Percutaneous Coronary Intervention in Patients With Reduced Ejection Fraction.
Liu Y; Chen SQ; Duan CY; Tan N; Chen JY; Zhou YL; Chen PY; Huang SJ; Liu XQ
Angiology; 2015 Aug; 66(7):625-30. PubMed ID: 25158831
[TBL] [Abstract][Full Text] [Related]
77. Incidence of contrast-induced acute kidney injury associated with diagnostic or interventional coronary angiography.
Morabito S; Pistolesi V; Benedetti G; Di Roma A; Colantonio R; Mancone M; Sardella G; Cibelli L; Ambrosino M; Polistena F; Pierucci A
J Nephrol; 2012; 25(6):1098-107. PubMed ID: 22383347
[TBL] [Abstract][Full Text] [Related]
78. Prevention of contrast-induced nephropathy in diabetic patients with impaired renal function: a randomized, double blind trial of sodium bicarbonate versus sodium chloride-based hydration.
Boucek P; Havrdova T; Oliyarnyk O; Skibova J; Pecenkova V; Pucelikova T; Sarkady D
Diabetes Res Clin Pract; 2013 Sep; 101(3):303-8. PubMed ID: 23835495
[TBL] [Abstract][Full Text] [Related]
79. Prevalence and Predictors of Contrast-Induced Nephropathy (CIN) in Patients with ST-Segment Elevation Myocardial Infarction (STEMI) Undergoing Percutaneous Coronary Intervention (PCI): A Meta-Analysis.
He H; Chen XR; Chen YQ; Niu TS; Liao YM
J Interv Cardiol; 2019; 2019():2750173. PubMed ID: 31772520
[TBL] [Abstract][Full Text] [Related]
80. Prediction of contrast-induced nephropathy by the serum creatinine level on the day following cardiac catheterization.
Watanabe M; Saito Y; Aonuma K; Hirayama A; Tamaki N; Tsutsui H; Murohara T; Ogawa H; Akasaka T; Yoshimura M; Sato A; Takayama T; Sakakibara M; Suzuki S; Ishigami K; Onoue K;
J Cardiol; 2016 Nov; 68(5):412-418. PubMed ID: 26708123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
